Trial Profile
The Effect of Lacosamide in Peripheral Neuropathic Pain: a Randomized, Double-blind, Placebo Controlled, Phenotype-stratified Study
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 17 Feb 2023
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary)
- Indications Neuropathic pain
- Focus Proof of concept; Therapeutic Use
- 23 Jun 2022 Status changed from recruiting to discontinued.
- 16 Aug 2021 Planned End Date changed from 1 May 2021 to 1 Oct 2022.
- 16 Aug 2021 Planned primary completion date changed from 1 May 2021 to 1 Oct 2022.